HIGHLIGHTS
- who: Helya Rostamkhani from the The current research was a randomized, double-blind, controlled parallel-group study including individuals with diabetes and ESRD who were on hemodialysisThe research was authorized by Tabriz University of Medical Sciences (IR.TBZMED.REC.1398.1188) and was filed on the Iranian Clinical Trials Registry website (IRCT, ). Prior to intervention, all participants provided informed permission in accordance with the Declaration of Helsinki. Participants have published the paper: The effect of zingiber officinale on prooxidant-antioxidant balance and glycemic control in diabetic patients with ESRD undergoing hemodialysis: a double-blind randomized control trial . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.